ResearcherIndiana University IndianapolisActive in the last 2 years
Fenil Shah
Matched on OpenAlex author ID A5061390507. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. Co-author DOI 10.1002/1878-0261.13552↗
- Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target. First author DOI 10.1186/s13046-021-02046-x↗
- Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. First author DOI 10.1021/acs.jmedchem.8b01957↗
- Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. First author DOI 10.1038/s41598-018-32034-9↗
- APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel pathways using single-cell RNA sequenci… Co-author DOI 10.1002/1878-0261.12138↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Melissa L. Fishel · 5 shared papers, 2017–2024 · strength 0.53
- Paper Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. DOI 10.1002/1878-0261.13552↗
- Paper Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential t… DOI 10.1186/s13046-021-02046-x↗
- Paper APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel… DOI 10.1002/1878-0261.12138↗
- Mark R. Kelley · 3 shared papers, 2017–2021 · strength 0.27
- Paper Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential t… DOI 10.1186/s13046-021-02046-x↗
- Paper APE1/Ref-1 knockdown in pancreatic ductal adenocarcinoma - characterizing gene expression changes and identifying novel… DOI 10.1002/1878-0261.12138↗
- Paper Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. DOI 10.1038/s41598-018-32034-9↗
- Alisa S. Wolberg · 1 shared paper, 2024 · strength 0.18
- Nayela N. Chowdhury · 1 shared paper, 2024 · strength 0.18
- Yi Yang · 1 shared paper, 2024 · strength 0.18
- Matthew J. Flick · 1 shared paper, 2024 · strength 0.18
- Hye‐ran Moon · 1 shared paper, 2021 · strength 0.11
- Bumsoo Han · 1 shared paper, 2021 · strength 0.11
- Silpa Gampala · 1 shared paper, 2021 · strength 0.11
- Derek P. Logsdon · 1 shared paper, 2018 · strength 0.08
- Andrew E. Shouksmith · 1 shared paper, 2019 · strength 0.07
- Patrick Thomas Gunning · 1 shared paper, 2019 · strength 0.07
- Stephen F Konieczny · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.